Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,580,512 CD55-interaction partners and the uses thereof
The invention relates to the use of a binding member that binds to both SCR1 and SCR2 of CD55 in the treatment of tumours and leukaemia. The binding member may...
US-9,580,511 Site-specific antibody-drug conjugation through glycoengineering
The current disclosure provides binding polypeptides (e.g., antibodies), and effector moiety conjugates thereof (e.g., antibody-drug conjugates or ADCs),...
US-9,580,509 Multispecific and multivalent binding proteins and uses thereof
The disclosure generally provides proteins that bind two epitopes (e.g., a first and a second epitope) and that are bivalent for binding to each of the first...
US-9,580,508 Bispecific EGFR/c-Met antibodies
Bispecific EGFR/c-Met antibodies and methods of making and using the molecules.
US-9,580,507 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to PD-L1 with high affinity....
US-9,580,506 Potency assays for antibody drug substance binding to an Fc receptor
The invention relates to a method of characterizing an antibody, which method is suitable as a potency assay for batch release of a pharmaceutical composition...
US-9,580,505 Human monoclonal antibodies to programmed death ligand 1 (PD-L1)
The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to PD-L1 with high affinity....
US-9,580,504 Pidilizumab monoclonal antibody therapy following stem cell transplantation
Methods for treating specific populations of cancer patients, specifically patients suffering from cancer who undergo stem cell transplantation and were...
US-9,580,503 Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof
The invention described herein is related to antibodies directed to the antigen TIM-1 and uses of such antibodies. In particular, there are provided fully human...
US-9,580,502 Compositions for selective reduction of circulating bioactive soluble TNF and methods for treating TNF-mediated...
An isolated or synthetic antibody or ligand is provided that specifically binds to an epitope of a dissociated monomer of human TNF. Such binding disrupts...
US-9,580,501 Anti-TNF alpha monoclonal secretory IgA antibodies and methods for treating inflammatory diseases
A monoclonal secretory IgA antibody, which binds to and neutralizes human TNF.alpha.. The secretory antibody is useful in treating a variety of inflammatory...
US-9,580,500 Compositions and methods for growth factor modulation
Provided herein are proteins, antibodies, assays and methods useful for modulating growth factor levels and/or activities. In some embodiments, such growth...
US-9,580,499 VEGFR2/Ang2 compounds
The present invention relates to compounds that bind to human vascular endothelial growth factor receptor-2 (VEGFR2) and human angiopoietin-2 (Ang2), and may be...
US-9,580,498 Monoclonal antibody for antagonizing and inhibiting binding of vascular endothelial growth factor to its...
A mouse monoclonal antibody for antagonizing and inhibiting binding of a vascular endothelial growth factor (VEGF) and its receptor (VEGF-R), and a heavy chain...
US-9,580,497 Antibody specifically binding to ANG2 and use thereof
An Ang2 specific antibody, a method of preventing and/or treating a disease related to the activation and/or overproduction (overexpression) of Ang2 by...
US-9,580,496 Therapeutic canine immunoglobulins and methods of using same
A method of preparing a canine antibody suitable for use in the therapeutic treatment of a canine is provided. In particular, there is provided immunoglobulins...
US-9,580,495 Anti-histone therapy for vascular necrosis in severe glomerulonephritis
Severe glomerulonephritis involves cell necrosis as well as NETosis, programmed neutrophil death leading to expulsion of nuclear chromatin and neutrophil...
US-9,580,494 Methods and device to neutralize soluble toxic agents in the brain
Methods, agents and devices for treating a patient to reduce accumulation of certain proteins in the brain are described. Such proteins include amyloid beta...
US-9,580,493 Anti-.alpha. synuclein binding molecules
Provided are anti-human .alpha.-synuclein-specific binding molecules, e.g., antibodies or antigen-binding fragments, variants or derivatives thereof, as methods...
US-9,580,492 Monoclonal antibodies that neutralize anthrax toxins
The present invention relates to monoclonal antibodies that bind or neutralize anthrax lethal factor (LF), edema factor (EF), and/or protective antigen (PA)....
US-9,580,491 Genetic engineering of non-human animals for the production of chimeric antibodies
The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain...
US-9,580,490 Uses of modified human tumor necrosis factor receptor-1 polypeptide
The present invention relates to new uses of modified human tumor necrosis factor receptor-1 (TNFRI) polypeptide, and more particularly, to uses thereof for...
US-9,580,489 VEGF antagonist formulations suitable for intravitreal administration
Ophthalmic formulations of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist are provided suitable for intravitreal administration...
US-9,580,488 Fusion tags and expression vector system for the expression of human parathyroid hormone (rhPTH)
The present invention provides for fusion tags of 20 to 40 amino acids having a sequence as given in FIG. 1, fusion tags sharing homology with these fusion...
US-9,580,487 Method of treating stomach or bowel-related disorders by administering glucagon-like-peptide-2 (GLP-2) analogues
GLP-2 analogs are disclosed which comprise one of more substitutions as compared to [hGly2]GLP-2 and which improved biological activity in vivo and/or improved...
US-9,580,486 Interleukin-2 muteins for the expansion of T-regulatory cells
Provided herein are IL-2 muteins and IL-2 mutein Fc-fusion molecules that preferentially expand and activate T regulatory cells and are amenable to large scale...
US-9,580,485 IL-12 immunoconjugate
Conjugate comprising interleukin-12 (IL-12) and a single chain targeting portion comprising two antigen binding sites. The targeting portion may comprise an...
US-9,580,484 Means and method for expression of authentic human epidermal growth factor and/or basic fibrolast growth factor...
The present invention relates to an engineered biological system, and in particular an Escherichia coli host. The host is incorporated with a DNA construct for...
US-9,580,483 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for treatment of diabetes
The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of...
US-9,580,482 Conformation-stabilized TRAP antigens
This invention relates to compositions and methods for eliciting an immune response against a parasite of the genus Plasmodium in a mammal.
US-9,580,481 Immunogenic compositions and methods therefor
The present invention provides compositions relating to viral capsomeres which comprise foreign immunogenic sequences for use in pharmaceutical compositions and...
US-9,580,480 Cell-directed synthesis of multifunctional nanopatterns and nanomaterials
Aspects of the invention relate to the engineering of biological nanostructures and materials.
US-9,580,479 Peptide tag and uses thereof
There are provided peptide tags derived from bacteriophytochrome (BphP) that is photoreceptor protein of Deinococcus <i/> radiodurans, an antibody capable...
US-9,580,478 Vaccines comprising heat-sensitive transgenes
The present disclosure provides temperature sensitive essential nucleic acid molecules from a psychrophilic bacterium, proteins encoded by the nucleic acid...
US-9,580,477 Approach to produce HIV-1 GP140 envelope protein trimers
An approach of producing recombinant trimers that mimic native HIV-1 envelope trimers is developed. A recombinant protein forming the recombinant trimers...
US-9,580,476 Adenoviral vector-based respiratory syncytial virus (RSV) vaccine
The invention provides an adenovirus or adenoviral vector characterized by comprising a nucleic acid sequence encoding one or more Respiratory Syncytial Virus...
US-9,580,475 Computationally optimized broadly reactive antigens for H1N1 influenza
Described herein is the generation of optimized H1N1 influenza HA polypeptides for eliciting a broadly reactive immune response to H1N1 influenza virus...
US-9,580,474 Polyionic papilloma virus-like particle (VLP) vaccines
The present invention relates to the field of vaccines. In particular, the present invention provides compositions and methods relating to virus-like particle...
US-9,580,473 Method of inhibiting HIV-1 binding to genital epithelia using V3 loop-specific peptides and GP340-specific...
This invention relates to methods compositions and devices for inhibiting infection of a subject's host cell by HIV. Specifically, the invention relates to...
US-9,580,472 Anti-microbial peptides and methods of use thereof
Anti-microbial peptides and methods of use are provided.
US-9,580,471 Process of preparing guanylate cyclase C agonists
The invention provides processes of preparing a peptide including a GCC agonist sequence selected from the group consisting of SEQ ID NOs: 1-249 described herein.
US-9,580,470 High-purity cyclopeptide crystal as well as preparation method and use thereof
A high purity cyclopeptide crystal has a structure shown by Formula I. R represents H or a cation forming a pharmaceutically acceptable salt. Also disclosed are...
US-9,580,469 Peptides for the treatment and early diagnosis of Alzheimer's disease and other tauopathies
The present invention relates to novel tau protein aggregate-binding peptides, homologs, fragments, parts and polymers thereof and to the use thereof.
US-9,580,468 Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
Conjugates comprising a targeting moiety specific for the CXCR4 and based on the polyphemusin-derived peptide and a therapeutic or imaging agent are provided....
US-9,580,467 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
Antiproliferative compounds having a structure represented by formula (II), where n, R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.5 are as defined herein, can...
US-9,580,466 Melanocortin-1 receptor-specific linear peptides
Melanocortin receptor-specific linear peptides of the formula ##STR00001## where R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8,...
US-9,580,465 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated...
The present invention provides peptides and peptide analogs that have tissue protective activities while having little or no potentially undesirable...
US-9,580,464 Anti-inflammatory proteins and peptides and methods of preparation and use thereof
Anti-inflammatory proteins/peptides are described, as well as their uses, methods of preparation, and methods of their detection. Specifically described are...
US-9,580,463 Hepatitis C virus inhibitors
Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit...
US-9,580,462 Protein extraction methods
The present invention relates to methods for isolating polypepitdes from cells. The methods may be used to isolate denatured polypeptides or native...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.